Analyst: Altera to catch Xilinx in 2012
Dylan McGrath, EETimes
3/9/2011 3:42 PM EST
SAN FRANCISCO—Altera Corp., the No. 2 player in the programmable logic market, is expected to catch up with market leader Xilinx Inc. in quarterly sales early next year, according to an analyst.
With a portfolio of FPGAs for high-, mid- and low-end markets, Altera (San Jose, Calif.) has set its sights on the application-specific standard product (ASSP) and embedded markets in addition to ASIC market, according to Hans Mosesmann, an analyst with Raymond James & Associates Inc.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- StreamDSP Serial FPDP Now Supports Xilinx UltraScale+ and Altera Stratix-10 FPGAs
- Intilop releases Network Security TOE Module for Altera and Xilinx FPGAs for their 10G & 40G Full TCP & UDP Offload Engines
- Intilop releases a Full TCP & UDP Host-Side Application interface for Altera and Xilinx FPGAs for Software's use that is implemented in Low latency hardware
- Intilop releases their 7 Gen. 1024 Full TCP & UDP Session Hardware Accelerator that requires no external memory on Altera & Xilinx FPGAs for all Hyper Performance Networking Systems
- Intilop delivers their Enhanced 16 Thousand TCP & UDP Session Hardware Accelerator on Altera and Xilinx FPGAs targeted towards all Hyper Performance Networking Systems
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






